BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18548115)

  • 21. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
    Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
    J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes.
    Kitao R; Fukumoto T; Hashimoto T; Izumi K; Jimbo H; Takemori C; Nishigori C
    J Dermatol Sci; 2021 Sep; 103(3):190-192. PubMed ID: 34489165
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons.
    Messingham KAN; Aust S; Helfenberger J; Parker KL; Schultz S; McKillip J; Narayanan NS; Fairley JA
    J Invest Dermatol; 2016 Mar; 136(3):721-723. PubMed ID: 27015458
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
    Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
    Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
    [No Abstract]   [Full Text] [Related]  

  • 27. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332.
    Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M
    J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"].
    Nishie W; Shimizu H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):472-7. PubMed ID: 20046014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
    Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
    J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
    Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
    J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
    [No Abstract]   [Full Text] [Related]  

  • 36. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
    Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    Tashima S; Konishi K; Koga H; Hashimoto T
    Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415
    [No Abstract]   [Full Text] [Related]  

  • 40. Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.
    Sakai A; Shimomura Y; Ansai O; Saito Y; Tomii K; Tsuchida Y; Iwata H; Ujiie H; Shimizu H; Abe R
    Br J Dermatol; 2017 Feb; 176(2):541-543. PubMed ID: 27714780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.